Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation.
about
Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.Up-regulation of BLT2 is critical for the survival of bladder cancer cellsBioactive lipoxygenase metabolites stimulation of NADPH oxidases and reactive oxygen speciesBlockade of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase and murine double minute synergistically induces Apoptosis in acute myeloid leukemia via BH3-only proteins Puma and Bim.Evaluation of apoptosis induction by concomitant inhibition of MEK, mTOR, and Bcl-2 in human acute myelogenous leukemia cells.The proinflammatory LTB4/BLT1 signal axis confers resistance to TGF-β1-induced growth inhibition by targeting Smad3 linker region.The Dual MEK/FLT3 Inhibitor E6201 Exerts Cytotoxic Activity against Acute Myeloid Leukemia Cells Harboring Resistance-Conferring FLT3 Mutations.A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cellsReversal of acquired drug resistance in FLT3-mutated acute myeloid leukemia cells via distinct drug combination strategies.The proteasome inhibitor bortezomib interacts synergistically with the histone deacetylase inhibitor suberoylanilide hydroxamic acid to induce T-leukemia/lymphoma cells apoptosis.Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway.The p53/mouse double minute 2 homolog complex deregulation in merlin-deficient tumours.Combination Therapy of PPARgamma Ligands and Inhibitors of Arachidonic Acid in Lung CancerLipoxygenase pathway receptor expression in ovarian cancer.
P2860
Q27851423-6A14E9E9-5AD8-4150-B8BD-8226FA3A387BQ28303710-BCDC1BF8-12AD-4818-B1CC-AD1A7BF82098Q28307771-9DAC168E-6932-408B-A046-10759084C542Q33732534-9F67ED7B-04AF-40A8-B93B-86DA9C8DB631Q33875609-D7099247-9010-4877-A0BD-EFED48C8FF63Q36561549-BD465F1B-5981-4161-86D1-947F665CDE11Q36693252-064F20D3-C70A-42AD-B0F0-FF9BD7B083F9Q37040640-765FF5F9-4D71-4740-B09E-BF41B7231504Q39016415-301D874C-42C5-4E28-82CA-AB51AC948758Q39873607-C33085A1-EEFA-4FC1-A41D-530E02DA4012Q40024347-7E1DDF3B-3DA4-4819-93DD-61E7FCF6DEE6Q41135859-3FC425CE-6BCA-44D8-A94D-C7621FBF3C47Q42126506-6975DE54-8353-482D-8D2F-C6FC2EE7C27EQ46638059-E92C15C1-6C8A-4227-A314-E420A3381D0E
P2860
Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Leukotriene B4 receptor inhibi ...... cells via JNK phosphorylation.
@en
Leukotriene B4 receptor inhibi ...... cells via JNK phosphorylation.
@nl
type
label
Leukotriene B4 receptor inhibi ...... cells via JNK phosphorylation.
@en
Leukotriene B4 receptor inhibi ...... cells via JNK phosphorylation.
@nl
prefLabel
Leukotriene B4 receptor inhibi ...... cells via JNK phosphorylation.
@en
Leukotriene B4 receptor inhibi ...... cells via JNK phosphorylation.
@nl
P2093
P2860
P356
P1433
P1476
Leukotriene B4 receptor inhibi ...... cells via JNK phosphorylation.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2403929
P577
2005-11-01T00:00:00Z